- Trials with a EudraCT protocol (134)
- Paediatric studies in scope of Art45 of the Paediatric Regulation (0)
134 result(s) found for: Neuropsychological tests.
Displaying page 1 of 7.
EudraCT Number: 2011-005971-18 | Sponsor Protocol Number: 13-617 | Start Date*: 2014-01-24 |
Sponsor Name:University Medical Center Utrecht | ||
Full Title: TimeToStop (TTS) Trial, A randomised controlled trial of early versus late antiepileptic drug withdrawal after pediatric epilepsy surgery | ||
Medical condition: We will investigate possible cognitive benifits of early antiepileptic drug withdrawal after pediatric epilepsy surgery. The concerning medical condition is refractory epilepsy | ||
Disease: | ||
Population Age: Infants and toddlers, Children, Adolescents, Under 18 | Gender: Male, Female | |
Trial protocol: NL (Prematurely Ended) | ||
Trial results: (No results available) |
EudraCT Number: 2014-003419-12 | Sponsor Protocol Number: SWEAR-1 | Start Date*: 2015-06-18 |
Sponsor Name:AZIENDA OSPEDALIERA SAN GERARDO, MONZA, ITALIA | ||
Full Title: A Pilot Randomized Controlled Trial of Switch to tenofovir disoproxil fumarate/emtricitabine/rilpivirine (TDF/FTC/RPV) versus continue TDF/FTC/efavirenz (EFV) treatment among virologically suppress... | ||
Medical condition: HIV INFECTION | ||
Disease: | ||
Population Age: Adults, Elderly | Gender: Male, Female | |
Trial protocol: IT (Prematurely Ended) | ||
Trial results: (No results available) |
EudraCT Number: 2016-004739-19 | Sponsor Protocol Number: OSU6162aSAH | Start Date*: 2017-06-16 |
Sponsor Name:Oslo University Hospital | ||
Full Title: OSU6162 IN THE TREATMENT OF FATIGUE AND OTHER NEUROPSYCHOLOGICAL SEQUELAE AFTER ANEURYSMAL SUBARACHNOIDAL HEMORRHAGE - A DOUBLE-BLIND, RANDOMISED, PLACEBO-CONTROLLED STUDY | ||
Medical condition: Fatigue and neuropsychological dysfunction after aneurysmal brain hemorrhage | ||
Disease: | ||
Population Age: Adults, Elderly | Gender: Male, Female | |
Trial protocol: NO (Completed) | ||
Trial results: View results |
EudraCT Number: 2020-001025-31 | Sponsor Protocol Number: 2019PI255 | Start Date*: 2021-07-29 |
Sponsor Name:CHRU Nancy | ||
Full Title: HIGHLIGHTING THE BENEFITS OF THERAPEUTIC GARDENS IN ALZHEIMER'S DISEASE with 18F-FDG Cerebral PET / CT | ||
Medical condition: atients followed at the Memory and Research Center (CMRR) and diagnosed with mild to moderate Alzheimer's disease (MMS 15-23) | ||
Disease: | ||
Population Age: Adults, Elderly | Gender: Male, Female | |
Trial protocol: FR (Ongoing) | ||
Trial results: (No results available) |
EudraCT Number: 2021-003607-17 | Sponsor Protocol Number: Rasmusscell | Start Date*: 2023-01-12 |
Sponsor Name:Fundación para la Investigación Biomédica del Hospital Universitario de La Princesa | ||
Full Title: Phase I, open-label clinical trial to evaluate the safety and clinical response of repeated-dose intra-arterial infusion of autologous mesenchymal cells in children and adolescents with refractory ... | ||
Medical condition: Autoimmune refractory epilepsy and Rasmussen Encephalitis | ||
Disease: | ||
Population Age: Infants and toddlers, Children, Adolescents, Under 18 | Gender: Male, Female | |
Trial protocol: ES (Ongoing) | ||
Trial results: (No results available) |
EudraCT Number: 2011-004357-82 | Sponsor Protocol Number: OSU6162ME1 | Start Date*: 2012-02-21 |
Sponsor Name:A. Carlsson Research AB | ||
Full Title: A randomized controlled trial of OSU6162 in treatment of Myalgic Encephalomyelitis/Chronic Fatigue Syndrome | ||
Medical condition: Myalgic Encephalomyelitis/Chronic Fatigue Syndrome | ||
Disease: | ||
Population Age: Adults | Gender: Male, Female | |
Trial protocol: SE (Completed) | ||
Trial results: (No results available) |
EudraCT Number: 2021-003228-34 | Sponsor Protocol Number: OCMDKET | Start Date*: 2022-04-25 |
Sponsor Name:Medical University of Vienna | ||
Full Title: Ketamine therapy and its effects on stress on neuropsychological function under stress in obsessive-compulsive disorder | ||
Medical condition: Obsessive-compulsive disorder | ||
Disease: | ||
Population Age: Adults | Gender: Male, Female | |
Trial protocol: AT (Trial now transitioned) | ||
Trial results: (No results available) |
EudraCT Number: 2010-019519-39 | Sponsor Protocol Number: RAPIT | Start Date*: 2012-03-14 |
Sponsor Name:Erasmus MC - Department of Neurology | ||
Full Title: Efficacy of RAD001/everolimus in Autism and NeuroPsychological deficits in children with TSC (RAPIT-trial) | ||
Medical condition: Tuberous Sclerosis Complex | ||
Disease: | ||
Population Age: Children, Adolescents, Under 18 | Gender: Male, Female | |
Trial protocol: NL (Completed) | ||
Trial results: (No results available) |
EudraCT Number: 2016-002326-36 | Sponsor Protocol Number: 2016-858 | Start Date*: 2016-11-09 | ||||||||||||||||
Sponsor Name:Region Hovedstadens psykiatriske hospital | ||||||||||||||||||
Full Title: Effects of erythropoietin (EPO) on cognitive side-effects of electroconvulsive therapy (ECT) (EPO-T) | ||||||||||||||||||
Medical condition: Unipolar/bipolar depression | ||||||||||||||||||
|
||||||||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | |||||||||||||||||
Trial protocol: DK (Completed) | ||||||||||||||||||
Trial results: View results |
EudraCT Number: 2021-006511-29 | Sponsor Protocol Number: PTC857-CNS-001-ALS | Start Date*: 2022-08-26 | |||||||||||
Sponsor Name:PTC Therapeutics, Inc. | |||||||||||||
Full Title: A PHASE 2, RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED, PARALLEL STUDY TO ASSESS THE EFFICACY, SAFETY, TOLERABILITY, PK, AND BIOMARKER EFFECTS OF PTC857 IN ADULT SUBJECTS WITH AMYOTROPHIC LATERAL ... | |||||||||||||
Medical condition: Amyotrophic Lateral Sclerosis (ALS) | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: FR (Trial now transitioned) DE (Ongoing) BE (Trial now transitioned) IT (Trial now transitioned) ES (Ongoing) CZ (Trial now transitioned) PL (Trial now transitioned) NL (Ongoing) NO (Trial now transitioned) SE (Trial now transitioned) | |||||||||||||
Trial results: (No results available) |
EudraCT Number: 2019-004498-18 | Sponsor Protocol Number: HUB-NEU-2019-01 | Start Date*: 2020-06-30 | |||||||||||
Sponsor Name:Dr. Jordi Gascón / Dra. Lola Ledesma | |||||||||||||
Full Title: EFFICACY AND SAFETY CLINICAL TRIAL WITH EFAVIRENZ IN PATIENTS DIAGNOSED WITH ADULT NIEMANN-PICK TYPE C WITH COGNITIVE IMPAIRMENT | |||||||||||||
Medical condition: Niemann Pick tipo C (NPC) | |||||||||||||
|
|||||||||||||
Population Age: Adolescents, Under 18, Adults | Gender: Male, Female | ||||||||||||
Trial protocol: ES (Ongoing) | |||||||||||||
Trial results: (No results available) |
EudraCT Number: 2021-000473-83 | Sponsor Protocol Number: PET-tau-FACEHBI | Start Date*: 2021-12-15 |
Sponsor Name:Fundació ACE-Institut Català de Neurociències Aplicades | ||
Full Title: PET imaging study of the brain tau deposit in individuals with subjective cognitive decline and mild cognitive impairment: FACEHBI cohort. | ||
Medical condition: Subjective cognitive impairment and mild cognitive decline in evaluation for diagnosis of Alzheimer's Disease. | ||
Disease: | ||
Population Age: Adults, Elderly | Gender: Male, Female | |
Trial protocol: ES (Ongoing) | ||
Trial results: (No results available) |
EudraCT Number: 2011-000794-31 | Sponsor Protocol Number: October2011,version5 | Start Date*: 2011-06-15 | |||||||||||
Sponsor Name:Dept. of Pharmacology | |||||||||||||
Full Title: Neurodegenerative Changes in Alzheimer’s Disease: Identifying potential effects of Victoza® on degenerative changes | |||||||||||||
Medical condition: Alzheimer's disease | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: DK (Completed) | |||||||||||||
Trial results: (No results available) |
EudraCT Number: 2015-003188-13 | Sponsor Protocol Number: CONIVAD | Start Date*: 2016-09-23 | |||||||||||
Sponsor Name:AZIENDA OSPEDALIERO-UNIVERSITARIA CAREGGI | |||||||||||||
Full Title: Pilot study on the association choline alphoscerate-nimodipine in patients with subcortical vascular cognitive impairment | |||||||||||||
Medical condition: Subcortical vascular cognitive impairment | |||||||||||||
|
|||||||||||||
Population Age: Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: IT (Prematurely Ended) | |||||||||||||
Trial results: (No results available) |
EudraCT Number: 2012-004785-18 | Sponsor Protocol Number: PKBoxing-1 | Start Date*: 2014-11-18 |
Sponsor Name:University Medical Center Groningen | ||
Full Title: PET imaging of neuroinflammatory consequences of chronic repetitive head injury in Muay Thai boxing | ||
Medical condition: n/a | ||
Disease: | ||
Population Age: Adults | Gender: Male | |
Trial protocol: NL (Ongoing) | ||
Trial results: (No results available) |
EudraCT Number: 2011-000925-60 | Sponsor Protocol Number: R1/11 | Start Date*: 2011-10-18 |
Sponsor Name:Kungälv Hospital | ||
Full Title: Effect of treatment with methylphenidate on mental fatigue (“brain fatigue”) and pain on persons who have suffered a traumatic brain injury or whip lash injury – a pilot study. | ||
Medical condition: Mental fatigue after traumatic brain injury or whip-lash injury | ||
Disease: | ||
Population Age: Adults | Gender: Male, Female | |
Trial protocol: SE (Ongoing) | ||
Trial results: (No results available) |
EudraCT Number: 2011-001650-29 | Sponsor Protocol Number: MF02/11 | Start Date*: 2011-12-19 |
Sponsor Name:A. Carlsson Research AB | ||
Full Title: TREATMENT OF MENTAL FATIGUE ("BRAIN FATIGUE") WITH THE DOPAMINERGIC STABILIZER OSU6162 AFTER STROKE AND MILD/MODERATE TRAUMATIC BRAIN INJURY– INCREASE OF PATIENT NUMBER | ||
Medical condition: Mental fatigue after stroke or mild to moderate head trauma | ||
Disease: | ||
Population Age: Adults | Gender: Male, Female | |
Trial protocol: SE (Completed) | ||
Trial results: (No results available) |
EudraCT Number: 2013-004244-37 | Sponsor Protocol Number: 13HH1824 | Start Date*: 2014-02-21 | |||||||||||
Sponsor Name:Imperial College London | Imperial College NHS Healthcare Trust | |||||||||||||
Full Title: The control of brain networks after traumatic brain injury: a neuroimaging and neuropsychological study of dopamine and cognition | |||||||||||||
Medical condition: Traumatic Brain Injury | |||||||||||||
|
|||||||||||||
Population Age: Adults | Gender: Male, Female | ||||||||||||
Trial protocol: GB (Completed) | |||||||||||||
Trial results: View results |
EudraCT Number: 2015-005416-15 | Sponsor Protocol Number: SIPA-SOS | Start Date*: 2016-10-20 |
Sponsor Name:Medical Center - University of Freiburg [...] | ||
Full Title: An open label phase II study of Sirolimus in patients with segmental overgrowth syndrome | ||
Medical condition: Segmental overgrowth syndrome | ||
Disease: | ||
Population Age: Children, Adolescents, Under 18, Adults | Gender: Male, Female | |
Trial protocol: DE (Completed) | ||
Trial results: View results |
EudraCT Number: 2017-002334-23 | Sponsor Protocol Number: 2017-03 | Start Date*: 2017-09-29 |
Sponsor Name:Dutch Breast Cancer Research Group (BOOG) | ||
Full Title: Selecting the Optimal position of CDK4/6 Inhibitors in HR+ Advanced breast cancer: the SONIA trial | ||
Medical condition: hormone receptor positive advanced breast cancer | ||
Disease: | ||
Population Age: Adults, Elderly | Gender: Female | |
Trial protocol: NL (Trial now transitioned) | ||
Trial results: (No results available) |
Subscribe to this Search
To subscribe to the RSS feed for this search click here
.
This will provide an RSS feed for clinical trials matching your search that have been added or updated in the last 7 days.
To subscribe to the RSS feed for this search click here

Download Options: | |
---|---|
Number of Trials to download: | |
Download Content: | |
Download Format: | |
Note, where multi-state trials are shown in search results, selecting "Full Trial details" will download full information for each of the member states/countries involved in the trial. |
